Backstories on the US Opioid Epidemic. Good Intentions Gone Bad, an Industry Gone Rogue, and Watch Dogs Gone to Sleep
- PMID: 29410156
- DOI: 10.1016/j.amjmed.2017.12.045
Backstories on the US Opioid Epidemic. Good Intentions Gone Bad, an Industry Gone Rogue, and Watch Dogs Gone to Sleep
Abstract
Epidemics of opioid use are old news in the United States, but an epidemic that kills over 200,000 Americans is not. A multiplicity of intertwined factors have brought us to this place. From 30,000 feet, it is the story of good intentions gone bad, a drug industry gone rogue, and government watch dog agencies gone to sleep. At ground level, it is the story of physicians unfamiliar with addictive drugs and drug addiction, new long-acting opioids deceptively marketed, cheap black tar heroin, encouragement to use opioids for chronic noncancer pain by professional organizations with conflicts of interest and without science, a culture intolerant to pain and tolerant to drug use, and the greedy response of the pharmaceutical industry and drug cartels to an expanding market opportunity. These factors are among those that have joined to form a tsunami of addiction and deaths that keeps on coming. A better understanding of them could speed the end of the present cycle of opioid abuse, perhaps prevent others, and inform future decisions about pain management.
Keywords: Addiction; Drug industry; Opioid-related deaths; Opioids; Pain.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
The US Opioid Crisis: Current Federal and State Legal Issues.Anesth Analg. 2017 Nov;125(5):1675-1681. doi: 10.1213/ANE.0000000000002403. Anesth Analg. 2017. PMID: 29049113 Review.
-
The Surgeon's Roles in Stemming the Prescription Opioid Abuse Epidemic.J Oral Maxillofac Surg. 2016 Jul;74(7):1291-3. doi: 10.1016/j.joms.2016.05.001. Epub 2016 May 6. J Oral Maxillofac Surg. 2016. PMID: 27156949 No abstract available.
-
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions.Anesth Analg. 2017 Nov;125(5):1769-1778. doi: 10.1213/ANE.0000000000002500. Anesth Analg. 2017. PMID: 29049121 Review.
-
Opioids with abuse-deterrent properties: A regulatory and technological overview.J Opioid Manag. 2017 Nov/Dec;13(6):397-413. doi: 10.5055/jom.2017.0417. J Opioid Manag. 2017. PMID: 29308587 Review.
-
Zohydro approval by food and drug administration: controversial or frightening?Pain Physician. 2014 Jul-Aug;17(4):E437-50. Pain Physician. 2014. PMID: 25054396 Review.
Cited by
-
Danger Close: What Opioid Prescribers Can Learn from the Way the Air Force Drops a Bomb.HSS J. 2019 Feb;15(1):8-11. doi: 10.1007/s11420-018-09667-7. Epub 2019 Jan 14. HSS J. 2019. PMID: 30863225 Free PMC article. No abstract available.
-
Prescribing trends of gabapentin, pregabalin, and oxycodone: a secondary analysis of primary care prescribing patterns in England.BJGP Open. 2019 Oct 29;3(3):bjgpopen19X101662. doi: 10.3399/bjgpopen19X101662. Print 2019 Oct. BJGP Open. 2019. PMID: 31581113 Free PMC article.
-
A Bridge to Nowhere? Challenging Outpatient Transitions of Care for Acute Pain Patients in the Opioid Epidemic Era.Mo Med. 2018 May-Jun;115(3):241-246. Mo Med. 2018. PMID: 30228730 Free PMC article.
-
Qualitative evaluation of an interdisciplinary chronic pain intervention: outcomes and barriers and facilitators to ongoing pain management.J Pain Res. 2019 Mar 1;12:865-878. doi: 10.2147/JPR.S185652. eCollection 2019. J Pain Res. 2019. PMID: 30881097 Free PMC article.
-
Lessons for Better Pain Management in the Future: Learning from the Past.Pain Ther. 2020 Dec;9(2):373-391. doi: 10.1007/s40122-020-00170-8. Epub 2020 May 14. Pain Ther. 2020. PMID: 32410070 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials